Atlas Trials

Esophagogastric Junction Carcinoma

4 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Esophagogastric Junction Carcinoma

RecordFirmDate
Study of Pembrolizumab (MK-3475) in Previously-Treated Participants With Advanced Carcinoma of the Esophagus or Esophagogastric Junction (MK-3475-180/KEYNOTE-180) (NCT02559687)Merck Sharp & Dohme LLC2015-12-02
Study of Pembrolizumab (MK-3475) Versus Investigator's Choice Standard Therapy for Participants With Advanced Esophageal/ Esophagogastric Junction Carcinoma That Progressed After First-Line Therapy (MK-3475-181/KEYNOTE-181) (NCT02564263)Merck Sharp & Dohme LLC2015-12-01

Track Esophagogastric Junction Carcinoma automatically

Every clearance here is in the API, with alerts when new ones post.